Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study.

Source:http://linkedlifedata.com/resource/pubmed/id/1450067

Download in:

View as

General Info

PMID
1450067